MustGrow BiologicsMGROF -0.61%29 Current Ratio is 1.88 as of Mar. 2026, which is 59% below its 10-year median of 4.63. GuruFocus rates MGROF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review. Among 261 Agriculture companies, MustGrow Biologics ranks better than 58.62% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. MustGrow Biologics's current ratio for the quarter that ended in Mar. 2026 was 1.88.
MustGrow Biologics has a current ratio of 1.88. It generally indicates good short-term financial strength.
The historical rank and industry rank for MustGrow Biologics's Current Ratio or its related term are showing as below:
MGROF'
s Current Ratio Range Over the Past 10 Years
Min: 0.03 Med: 4.63 Max: 11.65
Current: 1.88
During the past 10 years, MustGrow Biologics's highest Current Ratio was 11.65. The lowest was 0.03. And the median was 4.63.
MGROF's Current Ratio is ranked better than 58.62% of 261
companies
in the Agriculture industry
Industry Median: 1.55
vs MGROF: 1.88
MustGrow Biologics (OTCPK:MGROF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
MustGrow Biologics Current Ratio Related Terms
MustGrow Biologics Current Ratio Historical Data
* Premium members only.
The historical data trend for MustGrow Biologics's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, MustGrow Biologics's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MustGrow Biologics Current Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, MustGrow Biologics's Current Ratio distribution charts can be found below:
* The bar in red indicates where MustGrow Biologics's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MustGrow Biologics (MGROF) has a Current Ratio of 1.88 as of Mar. 2026. This is 59% below median its historical median of 4.63. Over the past decade, MustGrow Biologics' Current Ratio has ranged from 0.03 to 11.65. According to the industry distribution chart, MustGrow Biologics ranks #108 out of 261 companies in the Agriculture industry, placing it in the top 41.4%.
Is MustGrow Biologics' Current Ratio too high?
MustGrow Biologics' current Current Ratio of 1.88 is 59% below median its 10-year median of 4.63. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 11.65. The Agriculture industry median Current Ratio is 1.55. MustGrow Biologics' value of 1.88 is 21.3% above this industry median. Based on the distribution chart, MustGrow Biologics ranks #108 out of 261 companies in the Agriculture industry, which is above the industry midpoint. Overall, MustGrow Biologics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Current Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, MustGrow Biologics ranks #108 out of 261 companies for Current Ratio. This puts MustGrow Biologics in the upper half of its industry. The industry median Current Ratio is 1.55. MustGrow Biologics' value of 1.88 is 21.3% above this benchmark. Historically, MustGrow Biologics' own Current Ratio has ranged from 0.03 to 11.65 over the past decade. While the company's 10-year median is 4.63 vs. the industry median of 1.55, MustGrow Biologics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for an Agriculture company?
The median Current Ratio among Agriculture companies is 1.55, based on 261 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MustGrow Biologics's current Current Ratio of 1.88 is 21.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Agriculture industry, the median Current Ratio is 1.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MustGrow Biologics's current Current Ratio is 1.88, which is 59% below median its own 10-year median of 4.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current Current Ratio of 1.88. The current Current Ratio is 1.88, which is 59% below median its 10-year median of 4.63 and 21.3% above the Agriculture industry median of 1.55. MustGrow Biologics' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current Current Ratio is 1.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
29GF Score
Get the complete analysis for MGROF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MGROF has been successfully added to your 
